Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Tissue Engineering and Regenerative Medicine ; (6): 587-593, 2017.
Article Dans Anglais | WPRIM | ID: wpr-646589

Résumé

Human breast milk stem cells (hBSCs) contain a population of cells with the ability to differentiate into various cell lineages for cell therapy applications. The current study examined the differentiation potential of hBSCs into hepatocytes- like cells. The cells were isolated from the breast milk and were treated with hepatogenic medium containing hepatocyte growth factor, insulin-like growth factor and dexamethasone for 7 days subsequently; Oncostatin M was added to the culture media. RT-PCR and immunocytochemistry were performed to detect the hepatogenic markers. The glycogen storage and the ability of the cells to absorb and release indocynanin green were also tested. The data showed that most of the differentiated cells formed cell aggregates after the 30th day, with more cells accumulated to form spheroids. RT-PCR revealed the expression of the hepatic nuclear factor, albumin, cytokeratin 18 and 19, cytochrome P2B6, glucose-6-phospahtase and claudin. The functional assays also showed glycogen storage and omission of indicynine green. Our study demonstrated hBSCs are novel population that can differentiate into hepatocyte-like cells.


Sujets)
Humains , Région mammaire , Techniques de culture cellulaire , Lignage cellulaire , Thérapie cellulaire et tissulaire , Milieux de culture , Cytochromes , Dexaméthasone , Glycogène , Facteur de croissance des hépatocytes , Hépatocytes , Immunohistochimie , Kératine-18 , Cellules souches mésenchymateuses , Lait humain , Oncostatine M , Cellules souches
SÉLECTION CITATIONS
Détails de la recherche